Gujarat Terce Laboratories Limited
GUJTERC.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$282.05M
Close$
$67.61
92.9% upside
Current Fair Value
92.9% upsideUndervalued by 92.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $282.05 Million |
|---|---|
| Enterprise Value | $266.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.92 |
| Beta | 0.77 |
| Outstanding Shares | 7,791,300 |
Return
| Return on Equity | 21.46% |
|---|---|
| Return on Assets | 8.50% |
| Return on Invested Capital | 22.23% |
Valuation & Multiples
| P/E Ratio | 13.07 |
|---|---|
| PEG | 4.22 |
| Price to Sales | 0.6 |
| Price to Book Ratio | 2.92 |
| Enterprise Value to Revenue | 0.58 |
| Enterprise Value to EBIT | 8.81 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Gujarat Terce Laboratories Limited
235 employees
CEO: Aalap Natubhai Prajapati Gujarat Terce Laboratories Ltd. operates as a pharmaceutical enterprise, focusing on the production and distribution of various medicinal items. Its comprehensive product range addresses diverse therapeutic areas such as anti-fungal, ant...